Cancer Center Services – Frequently Asked Questions
What should a cancer center evaluate before expanding a service, facility, or network?
The evaluation should consider market demand, provider capacity, current organizational performance, facility requirements, and how the proposed expansion fits within the broader network strategy. Leaders should also assess readiness for value-based care and determine what clinical, operational, and financial resources will be needed to support the expanded program.
What transaction and valuation needs may arise in oncology?
An oncology transaction may require financial and operational due diligence, Quality of Earnings (QoE) analysis, business or brand valuation, provider compensation review, and valuation of machinery and equipment. The scope should reflect the transaction structure, the assets being transferred, the compensation arrangements involved, and the integration work required after closing.
How can a cancer center improve operational consistency across the care continuum?
Operational assessments can identify where clinical, financial, and administrative processes are not working together effectively. Care pathways, quality scorecards, implementation plans, and clear policies and procedures can then help establish more consistent expectations, responsibilities, and performance measures across oncology services.
Which compliance and pharmacy issues should cancer centers review?
Cancer centers should review coding, medical necessity, pharmacy operations, 340B participation, and the controls used to prepare for regulatory audits. The review should also consider corrective action planning, pharmacy benefit management audits, post-audit follow-up, and broader compliance risks that may affect oncology operations.
What services does PYA’s Clinical Research Administration Office provide for oncology programs?
PYA’s Clinical Research Administration Office coordinates financial and regulatory activities associated with clinical research, including study activation, ongoing maintenance, and post-award revenue cycle management. This support helps connect the financial, regulatory, billing, collection, and administrative responsibilities that continue throughout the life of a clinical trial.
